← Open Payments lookup

LEVI HONGSERMEIER: Open Payments

NPI 1700461639 · REDDING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,715 in 128 payments from 13 companies in 2025. Trend: 2023 $2,735 · 2024 $2,512 · 2025 $2,715

Food & beverage: $2,715
CompanyPaymentsAmount
ABBVIE INC.22$565
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)30$527
Neurocrine BioSciences, Inc.14$488
Janssen Pharmaceuticals, Inc14$303
Axsome Therapeutics, Inc.14$207
Otsuka America Pharmaceutical, Inc.8$169
Vanda Pharmaceuticals Inc.11$137
Teva Pharmaceuticals USA, Inc.4$98
E.R. Squibb & Sons, L.L.C.3$66
Collegium Pharmaceutical, Inc.4$63

Products named: VRAYLAR, CAPLYTA, INGREZZA, SPRAVATO, Auvelity, REXULTI, FANAPT, COBENFY.

Industry payments across CA — which companies pay providers there.